Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATLAS: Prazosin in PTSD-Related Insulin Resistance
NCT07862712Phase 4Not yet recruiting
- Sponsor
- VA Office of Research & Development
- Start
- Mar 2027
- Primary completion
- Dec 2031
- Countries
- 1
01
Overview
A Phase 4 trial of prazosin in insulin resistance (IR), sponsored by VA Office of Research & Development. Planned start Mar 2027; status: not yet recruiting.
02
Drugs
prazosin
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT07862712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07862712.